Jun Ma

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Caicun Zhou, Yi‐Long Wu, Gongyan Chen et al. · The Lancet Oncology · 2011 · 4K citations

Medicine, Pathology, Bronchial Neoplasm +8

Degradation of sulfamethoxazole by UV, UV/H2O2 and UV/persulfate (PDS): Formation of oxidation products and effect of bicarbonate

Yi Yang, Xinglin Lu, Jin Jiang et al. · Water Research · 2017 · 601 citations

Advanced Oxidation Process, Chemical Engineering, Environmental Chemistry +11

Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial

Jie Jin, Jianxiang Wang, Feifei Chen et al. · The Lancet Oncology · 2013 · 157 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +9

Facile syntheses of cylindrical molecular brushes by a sequential RAFT and ROMP “grafting‐through” methodology

Li Zhou, Ke Zhang, Jun Ma et al. · Journal of Polymer Science Part A Polymer Chemistry · 2009 · 148 citations · Full text

Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016

Weiping Liu, Jiangmei Liu, Yuqin Song et al. · Journal of Hematology & Oncology · 2019 · 146 citations · Full text